Hepatitis C death rates rise, 1 in 33 baby boomers has disease
hepatitis c symptoms. by admin on Feb 22, 2012 • 5:18 am No Comments. Skip to search. New User? Register Sign In Help Upgrade to Safer IE8 Notifications Help Mail My Y! Yahoo! Yahoo! Finance comarketing component
Novartis agreed to pay as much as $440 million for the rights to an experimental drug against hepatitis C, joining Foster City's Gilead Sciences and Bristol-Myers Squibb in seeking deals to gain medicines against the virus.
Using a computer model of hepatitis C, Stanford researchers have determined that two new virus-targeting drugs called protease inhibitors are a cost-effective way to treat patients with advanced disease. As my colleague explains in a press release: The
Using a computer model of hepatitis C, Stanford researchers have determined that two new virus-targeting drugs called protease inhibitors are a cost-effective way to treat patients with advanced disease. As my colleague explains in a press release: The
LAS VEGAS (AP) — Court-ordered talks have yielded settlements in 41 lawsuits involving drug companies blamed for supplying an anesthetic to Las Vegas medical clinics where health officials say patients contracted incurable hepatitis C through unsafe
No comments yet.